Kite Reports First Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall St futures rise on Mideast deal optimism; SpaceX debut in focus
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Oil falls to near two-month lows as Trump calls off threatened strikes on Iran
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Wall St set to gain on tech rebound, Middle East in focus
Kite Pharma (KITE) Tops Q1 EPS by 44c
May 8, 2017 8:01 AM EDTKite Pharma (NASDAQ: KITE) reported Q1 EPS of ($1.28), $0.44 better than the analyst estimate of ($1.72). Revenue for the quarter came in at $9.8 million versus the consensus estimate of $12.31 million.
For earnings history and earnings-related data on Kite Pharma (KITE) click here.
... More